Associated Papers
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry.
D'Erasmo L et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2025
41099101 (PubMed )
Supplement: atv-45-2264-s001.pdf
Burden of Mendelian disorders in a large Middle Eastern biobank.
Aamer W et al.
Genome Medicine, 2024
38584274 (PubMed )
Supplement: 13073_2024_1307_MOESM1_ESM.xlsx › Table_S3
The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation.
Yang Z et al.
The Journal of Nutritional Biochemistry, 2021
Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias.
Dron JS et al.
Bmc Medical Genomics, 2020
32041611 (PubMed )
Supplement: 12920_2020_669_MOESM1_ESM.xlsx › Supp_Table_4
Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia.
Cefalù AB et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2015
The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism.
Lee JH et al.
Nature Medicine, 2011
Hypertriglyceridemia-induced acute pancreatitis in pregnancy associated with CREB3L3 mutation.
Gurevitz C et al.
Journal of Clinical Lipidology, 0
Select a paper to view details